The Biden administration on Friday put in place stringent curbs aimed at thwarting rogue insurance brokers from switching consumers’ Affordable Care Act plans without their consent.
Meta Title: OSE Immunotherapeutics SA Files Patent for Anti-human SIRPa Antibody
Share this article According to GlobalData’s company profile on OSE Immunotherapeutics, Personalized cancer vaccines was a key innovation area identified from patents. OSE Immunotherapeutics‘s grant